¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Diabetes, obesity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® obesity ÇÑ±Û ºñ¸¸Áõ
¼³¸í   
  ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î Ã¼ÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª Ã¼Áö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â Ã¼ÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î Çؼ­ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú Ã¼Áö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³­´Ù. ºñ¸¸, Æ¯È÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, Æ¯È÷ ¼ºÀκ´À̶ó°í Çϴ ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â Ã¼ÁßÀ» ÃøÁ¤Çϴ ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡Çϴ ÀÓ»óÀûÀΠ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇϴ ¹æ¹ýÀ̸ç [½ÅÀå(cm)£­100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È­½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼Áߣ­Ç¥ÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, È¯°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼­, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù.
¿µ¹® childhood diabetes ÇÑ±Û ¼Ò¾Æ´ç´¢º´
¼³¸í   
  ¼Ò¾Æ¿¡ ³ªÅ¸³ª´Â ´ç´¢º´. ´ç´¢º´Àº Àν¶¸° ºÎÁ·À¸·Î Ã¼³» Æ÷µµ´ç ÀÌ¿ëÀÌ ÀúÇϵǾî Åº¼öÈ­¹°-Áö¹æ-´Ü¹éÁú ´ë»ç°¡ ÀåÇØ¸¦ ÀÏÀ¸Å°´Â Áúº´À¸·Î, ¼ºÀÎÇü ´ç´¢º´°ú ¿¬¼ÒÇü ´ç´¢º´ÀÌ ÀÖ´Ù. ¼ºÀÎÇüÀº Àν¶¸°ÀÇ »ó´ëÀû ºÎÁ·, Áï ºñ¸¸À¸·Î ÀÎÇÑ Àν¶¸° °¨¼ö¼ºÀÇ ÀúÇÏ °á°ú Àν¶¸° Çʿ䷮ÀÇ Áõ´ë¿¡¼­ ¿À´Â °ÍÀ̸ç, ¼Ò¾ÆÇü ´ç´¢º´Àº ÀÌÀÚÀÇ ¶û°Ô¸£Çѽº¼¶ º£Å¸(¥â)¼¼Æ÷ÀÇ ÀåÇØ·Î ÀÎÇÑ Àν¶¸°ÀÇ Àý´ëÀû °áÇÌ¿¡¼­ ¿Â´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ±ÇÀåÀ¸·Î 15¼¼ ÀÌÀü¿¡ ¹ßº´Çϴ ´ç´¢º´À» ¸ðµÎ ¼Ò¾Æ´ç´¢º´À̶ó Çϴµ¥, ¾î¸°ÀÌ¿¡°Ôµµ °£È¤ ¼ºÀÎÇü(¶Ç´Â ºñ¸¸Çü) ´ç´¢º´ÀÌ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ´ç´¢º´À̶ó ÇÔÀº ¼Ò¾Æ±â¿¡ ¹ßº´Çϴ ¼Ò¾ÆÇü°ú ¼ºÀÎÇü ´ç´¢º´ÀÇ ÃÑĪÀ̶ó ÇÒ ¼ö ÀÖ´Ù. ÇöÀç±îÁö Åë°è¿¡ ÀÇÇϸé ÀüüÀα¸ÀÇ ¾à 5%´Â ´ç´¢º´À» °¡Áö°í ÀÖÀ¸¸ç, ±× °¡¿îµ¥ ¾à 2%°¡ 15¼¼ ÀÌÀü¿¡ ¹ßº´Çϴ °ÍÀ¸·Î ¾Ë·ÁÁ³´Ù.
¿µ¹® diabetes insipidus ÇÑ±Û ¿äºØÁõ
¼³¸í   
  1ÀÏ ¼Òº¯ÀÇ ¾çÀÌ 4~15¸®ÅͷΠº´ÀûÀ¸·Î Áõ°¡Çϴ »óÅÂ. ÀÌ Áõ»óÀº ³úÀÇ ¹Ù´Ú¿¡ ºÙ¾î Àִ ȣ¸£¸óÀ» ÁַΠºÐºñÇϴ ÀÛÀº ±â°üÀΠ³úÇϼöü ÈÄ¿±¿¡¼­ ºÐºñµÇ¾î ¼öºÐÀÇ Èí¼ö¸¦ ÃËÁøÇÏ¿© Ã¼³»¿¡ ¼öºÐÀÇ ¾çÀ» ´ÃÀ̴ ¿ªÇÒÀ» Ç졒ʵ¿½Ã¿¡ Ç÷°üÀ» ¼öÃà½Ã۴ ÀÛ¿ëÀÌ ÀÖ¾î Ç÷¾ÐÀ» »ó½Â½Ã۴ ¿ªÇÒµµ Çϴ ADH(Ç×ÀÌ´¢È£¸£¸ó)ÀÇ ºÎÁ·¿¡ ÀÇÇÑ´Ù. ADH°¡ ºÎÁ·µÉ °æ¿ì¿¡´Â ÄáÆÏ¿¡¼­ ¼öºÐÀÇ Èí¼ö°¡ ÀϾÁö ¾Ê¾Æ¼­ ¸¹Àº ¾çÀÇ ¼öºÐÀÌ ½ÅÀåÀ» ÅëÇØ °É·¯Á®¼­ ¼Òº¯À¸·Î ³ª¿À°Ô µÈ´Ù.
¿µ¹® IDDM(Insulin-Dependent Diabetes Mellitus) ÇÑ±Û Àν¶¸°ÀÇÁ¸´ç´¢º´
¼³¸í   
  IDDMÀº ´ç´¢º´ÀÇ Ä¡·á¿¡ ¹Ýµå½Ã Àν¶¸°ÀÌ ÇÊ¿äÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. ÁַΠ¿øÀÎÀÌ ÀÌÀÚ¿¡ Àִ Àν¶¸°À» ºÐºñÇϴ ¼¼Æ÷ÀÇ ÆÄ±«À̸ç À̷ΠÀÎÇØ¼­ ´ç´¢º´ÀÇ Ä¡·áÁ¦·Î ¾²À̴ Àν¶¸°ÀÇ ºÐºñ¸¦ ÃËÁøÇϴ ¾à¹°ÀÌ ÀÌ IDDM¿¡¼­´Â ¾²ÀÏ ¼ö°¡ ¾ø°í ¿ÀÁ÷ Àν¶¸°¸¸ÀÌ Ä¡·áÁ¦·Î ¾µ ¼ö°¡ ÀÖ´Ù. ÀüÇüÀûÀΠÀν¶¸° ÀÇÁ¸Çü ´ç´¢º´Àº ¼Ò¾Æ¿¡¼­ ÈçÈ÷ ¹ß»ýÇϰí Àν¶¸° ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ Àν¶¸° ºÐºñ´ÉÀº °ÅÀÇ ¾ø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adult-onset obesity
    ¼ºÀιߺ´ºñ¸¸
  • alimentary obesity
    ½Ä»çºñ¸¸
  • android obesity
    ³²¼ºÇüºñ¸¸
  • exogenous obesity
    ¿ÜÀκñ¸¸, ½Ä»çºñ¸¸
  • endogenous obesity
    ³»Àκñ¸¸, ´ë»çºñ¸¸
  • hyperplasmic obesity
    ÇüÁúÁõ½Äºñ¸¸
  • hypogonadal obesity
    »ý½Ä»ùÀúÇϺñ¸¸
  • hypothalamic obesity
    ½Ã»óÇϺκñ¸¸
  • morbid obesity
    º´Àûºñ¸¸
  • obesity
    1. ºñ¸¸ 2. ºñ¸¸Áõ
  • obesity index
    ºñ¸¸Áö¼ö
  • paradoxical obesity
    ¸ð¼øºñ¸¸
  • asymptomatic diabetes
    ¹«Áõ»ó´ç´¢º´
  • brittle diabetes
    ºÒ¾ÈÁ¤´ç´¢º´
  • bronze diabetes
    ûµ¿»ö´ç´¢º´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity index
    ºñ¸¸Áö¼ö
  • obesity
    ºñ¸¸, ºñ¸¸Áõ
  • diabetes
    ´ç´¢º´
  • diabetes insipidus
    ¿äºØÁõ
  • diabetes mellitus
    ´ç´¢º´
  • gestational diabetes
    ÀӽŴ索º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alimentary obesity
    (¢¡exogenous obesity) ½Ä»çºñ¸¸
  • endogenous obesity
    ´ë»çºñ¸¸
  • exogenous obesity
    ½Ä»çºñ¸¸
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Äºñ¸¸Áõ
  • hypogonad obesity
    ¼º±â´ÉÀúÇϺñ¸¸(Áõ)
  • hypothalamic obesity
    ½Ã»óÇϺκñ¸¸(Áõ)
  • obesity index
    ºñ¸¸Áö¼ö
  • morbid obesity
    º´Àûºñ¸¸
  • obesity
    ºñ¸¸(Áõ)
  • paradoxical obesity
    ±âÀ̺ñ¸¸
  • truncal obesity
    ¸öÅëºñ¸¸Áõ
  • asymptomatic diabetes
    ¹«Áõ»ó´ç´¢º´
  • brittle diabetes
    ºÒ¾ÈÁ¤Çü´ç´¢º´
  • bronze diabetes
    (¢¡hemochromatosis) Ç÷»ö¼ÒÄ§ÂøÁõ
  • diabetes
    ´ç´¢º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hypothalamic obesity
    ½Ã»óÇϺκñ´ëÁõ(ÝþÓÞñø)
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Ä¼º ºñ¸¸Áõ(úìíìñòãÖàõÝþØ»ñø).
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • pituitary obesity
    Çϼöü¼º ºñ¸¸Áõ(¡­ÝþØ»ñø).
  • pituitary obesity
    Çϼöü¼º ºñ¸¸Áõ(ù»á÷ô÷àõ ÝþØ»ñø)
  • Hepatic glucogenesis, in diabetes mellitus
    °£´ç»ý¼º(ÊÜÓØßæà÷)
  • genetic diabetes
    À¯ÀüÀû ´ç´¢º´.
  • genuine diabetes
    Áø¼º´ç´¢º´(òØàõÓØèñÜ»).
  • gestational diabetes
    Àӽżº ´ç´¢(º´)
  • gouty diabetes
    Åëdz¼º ´ç´¢º´.
  • growth onset type diabetes
    Ãʱâ´ç´¢º´.
  • iatrogenic diabetes
    ÀÇ(¿ø)¼º ´ç´¢º´(ì¢ê«àõÓØèñÜ»), ÀÇÀμº ´ç´¢º´.
  • phosphate diabetes
    Àλ꿰´ç´¢
  • pituitary diabetes
    Çϼöü¼º ´ç´¢º´(ù»á÷ô÷àõ ÓØèñÜ»)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • central obesity
    Á߽ɺκñ¸¸(Áõ), ±¸°£ºñ¸¸.
  • exogenous obesity
    ¿ÜÀμº ºñ¸¸Áõ.
  • hyperplasmic obesity
    Ç÷ÀåÁõ½Ä¼º ºñ¸¸Áõ(úìíìñòãÖàõÝþØ»ñø).
  • hypogonadal obesity
    ¼º±â´ÉÀúÇϼº ºñ¸¸(Áõ).
  • hypothalamic obesity
    ½Ã»óÇϺμº ºñ¸¸(Áõ)(¡­ÝþØ»ñø).
  • morbid obesity
    º´Àû ºñ¸¸
  • obesitas =obesity
    ºñ¸¸(Áõ)(ÝþØ»ñø).
  • obesity
    ºñ¸¸(Áõ)
  • obesity
    ºñ¸¸(ÝþØ»), ºñ¹Ý(Ýþ?)
  • obesity
    ºñ¸¸Áõ
  • obesity diet
    ºñ¸¸Áõ½ÄÀÌ(¡­ãÝìÈ).
  • obesity heart disease
    ºñ¸¸½ÉÀ庴 (¡­ãýíôÜ»).
  • obesity index
    ºñ¸¸Áö¼ö.
  • paradoxical obesity
    ±âÀ̺ñ¸¸Áõ(Ðôì¶ ÝþØ»ñø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸(ÝþØ»)
  • adult-onset diabetes
    ¼ºÀÎ ´ç´¢º´(à÷ìÑ ÓØÒãÜ»)
  • diabetes
    ´ç´¢º´(ÓØÒãÜ»)
  • diabetes innocens
    "ºñÃ鼺´ç´¢º´(ÞªõýàõÓØÒãÜ»), (ÔÒ) renal glucosuria"
  • diabetes insipidus
    ¿ä
  • diabetes mellitus
    ´ç´¢º´(ÓØÒãÜ»)
  • starvation diabetes
    ±â¾Æ ´ç´¢º´(ÑÆä»ÓØÒãÜ»)
  • steroid diabetes
    ½ºÅ×·ÎÀÌµå ´ç´¢º´(ÓØÒãÜ»)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸(Áõ)
  • pituitary obesity
    Çϼöü¼ººñ¸¸Áõ
  • truncal obesity
    Á߽ɼººñ¸¸
  • diabetes
    ´ç´¢º´
  • diabetes insipidus
    ¿äºØÁõ
  • diabetes mellitus
    Áø¼º´ç´¢º´
  • insulin dependent diabetes mellitus
    Àν¶¸°ÀÇÁ¸¼º´ç´¢º´
  • juvenile diabetes mellitus
    ¿¬¼Ò¼º´ç´¢º´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CDI cell-directed inhibitor; central or chronic diabetes insipidus; Children's Depression Inventory; col...
DIDMOA diabetes insipidus-diabetes mellitus-optic atrophy [syndrome]
DIMOAD diabetes insipidus, diabetes mellitus, optic atrophy, deafness
COI Central Obesity Index; certificate of insurance; cost of illness
HHHO hypotonia, hypomentia, hypogonadism, obesity [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DIO Diet-induced obesity
OHS Obesity Hypoventilation Syndrome
%OB obesity
ADA American Diabetes Association
ABCD Appropriate Blood Pressure Control in Diabetes
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 22008
    JournalTitle: Diabetes, obesity & metabolism.
    MedAbbr: Diabetes Obes Metab
    ISSN: 1462-8902
    ESSN:
    IsoAbbr:
    NlmId: 100883645
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adrenocortical obesity
    ºÎ½Å ÇÇÁú¼º ºñ¸¸, ºÎ½Å ÇÇÁú¼º ºñ¸¸Áõ
  • hypogonadal obesity
    ¼º ±â´É ÀúÇϼº ºñ¸¸, ¼º ±â´É ÀúÇϼº ºñ¸¸Áõ
  • obesity
    ºñ¸¸, ºñ¸¸Áõ
    1. ½Åü¿¡ Áö¹æÀÇ °úµµÇÑ ÃàÀûÀ¸·Î °ñ°Ý°ú À°Ã¼ÀÇ ¿ä±¸ ÇѰ踦 ³Ñ¾î¼­¼­ ¸ö¹«°Ô°¡ Áõ°¡ÇÏ´Â °Í. 2. Áö¹æ Á¶Á÷ÀÇ ´ë»ç Àå¾Ö¿¡ ÀÇÇÏ¿© Áö¹æÀÇ ¿¬¼Ò°¡ ºÒÃæºÐÇÏ°Ô µÇ¾î ½ÅüÀÇ ¿©·¯ °÷¿¡ Áö¹æÀÇ ÀÌ»ó Ä§ÂøÀÌ ÀϾ´Â Áõ¼¼. Áö¹æ °ú´ÙÁõÀ̶ó°íµµ ÇÑ´Ù. ´ë°³´Â ³»ºÐºñ¼±ÀÇ ÀÌ»ó, ¶Ç´Â ³»ºÐºñ¼± »óÈ£°£ÀÇ ÀÌ»ó¿¡ ±âÀÎÇÑ´Ù. ¿¹¸¦ µé¸é, ¼º¼±¼º ºñ¸¸º´, °©»ó¼± ±â´É ÀúÇϳª, ºÎ½Å ÇÇÁú ±â´É Ç×Áø, Çϼöü °£³ú°è Àå¾Ö¿¡ ÀÇÇÑ ºñ¸¸ÁõÀÌ ÀÖÀ¸¸ç, À̵éÀ» ³»Àμº ºñ¸¸ÁõÀ̶ó°í ÇÑ´Ù. À̰Ϳ¡ ´ëÇØ °úµµÀÇ ¿µ¾ç ¼·Ãë·Î ÀÎÇÑ °ÍÀ» ¿ÜÀμº ºñ¸¸ÁõÀ̶ó°í ÇÑ´Ù. 3. ÈçÇÑ ¹®Á¦À̳ª Áõ¸íÇÒ ¸¸ÇÑ ³»ºÐºñÀû ¿øÀÎÀº µå¹°¸ç, ÈçÈ÷ ´Ù¸¥ ¿øÀο¡ ÀÇÇÑ´Ù. ½ÅüÀû Ȱµ¿ ÀúÇÏ¿¡ ÀÇÇØ¼­ ¾à°£ÀÇ Ã¼Áß Áõ°¡°¡ À¯¹ßµÇ¸ç ³ëÈ­µµ ºñ¸¸Áõ¿¡ ¿ªÇÒÀ» ÇÑ´Ù. Áï 20¼¼¿¡¼­ 63¼¼ »çÀÌÀÇ ¼ºÀο¡¼­´Â ¿¬°£ 0.1kg/§³ÀÇ Ã¼Áß Áõ°¡°¡ ÀÖ´Ù. À¯ÀüÀº °¡Àå Áß¿äÇÑ ºñ¸¸ÁõÀÇ °áÁ¤ ÀÎÀÚÀÌ´Ù. ½ÖµÕÀÌ ¿¬±¸¿¡ ÀÇÇÏ¸é ºñ¸¸ÁõÀÇ 70%´Â À¯ÀüÀû ÀÎÀÚ¿¡ ÀÇÇÑ´Ù´Â °ÍÀÌ ½Ã»çµÇ¾ú´Ù. ºñ¸¸ÁõÀ» Á¶ÀýÇÏ´Â À¯Àü ÀÎÀÚ
  • paradoxical obesity
    ±âÀÌ ºñ¸¸Áõ
  • truncal obesity
    Á߽ɼº ºñ¸¸
  • alimentary diabetes
    ½ÄÀ̼º ´ç´¢º´
  • diabetes
    ´ç´¢º´
    Áø¼º ´ç´¢º´À̳ª ¿äºØÁõ°ú °°ÀÌ °úÀ×ÀÇ ¿ä ¹è¼³À» Ư¡À¸·Î Çϴ ȯÀÚ¸¦ °¡¸®Å°´Â ÀÏ¹Ý ¿ë¾î. diabetes ¸¸ »ç¿ëµÉ ¶§´Â diabetes millitus
  • diabetes innocens
    ºñÃ鼺 ´ç´¢º´
  • diabetes intermittens
    °£Ç漺 ´ç´¢, °£Ç漺 ´ç´¢º´
  • diabetes test
    ´ç´¢º´ ½ÃÇè
  • endocrine diabetes
    ³»ºÐºñ¼º ´ç´¢º´
  • insulin dependent diabetes mellitus
    Àν¶¸° ÀÇÁ¸¼º ´ç´¢º´
  • juvenile diabetes mellitus
    ¿¬¼Ò¼º ´ç´¢º´
    ±Ø½ÉÇÑ Áø¼º ´ç´¢º´À¸·Î, º¸ÅëÀº 25¼¼ ÀÌÀü¿¡ °©Àڱ⠹߻ýÇϰí Ä¡·á ¶Ç´Â Á¶ÀýÇϱⰡ °ï¶õÇÏ´Ù. Ç÷Àå³» Àν¶¸°ÀÇ ¾çÀÌ Á¾Á¾ °áÇ̵Ǿî ÀÖ°í ketoacidosis°¡ ÈçÈ÷ ³ªÅ¸³­´Ù. ³»º¹¿ëÀÇ ÀúÇ÷´ç ¾à¹°°ú ½ÄÀÌ ¿ä¹ýÀ¸·Î´Â °ÅÀÇ È¿°ú°¡ ¾ø°í, ¸ÅÀÏ Àν¶¸° Áֻ縦 ÇÊ¿ä·Î ÇÑ´Ù.
  • Lancereaux's diabetes
    ¶û¼¼·Î ´ç´¢º´
    ÁßÁõ¼º ´ç´¢º´À¸·Î¼­, ÃéÀåÀÇ ½ÉÇÑ º´º¯À» ¼ö¹ÝÇÑ´Ù.
  • latent diabetes
    ÀáÀ缺 ´ç´¢º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anti-obesity agents Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity.
(12 Dec 1998)
central obesity The deposition of obesity around the trunk sparing the limbs.
(27 Sep 1997)
risks, obesity-related Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness)
(12 Dec 1998)
morbid obesity Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition.
Simple obesity, obesity resulting when caloric intake exceeds energy expenditure.
(05 Mar 2000)
hypothalamic obesity with hypogonadism A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
diseases, obesity-related Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness).
(12 Dec 1998)
obesity <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body.
Origin: L. Obesus = fat
(18 Nov 1997)
obesity index Body weight divided by body volume.
(05 Mar 2000)
obesity, morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders.
(12 Dec 1998)
obesity-related diseases Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness).
(12 Dec 1998)
adult-onset diabetes <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop.
(05 Mar 2000)
alimentary diabetes Glycosuria developing after the ingestion of a moderate amount of sugar or starch, which normally is disposed of without appearing in the urine, because rate of intestinal absorption exceeds capacity of the liver and the other tissues to remove the glucose, thus allowing blood glucose levels to become high enough for renal excretion to occur.
Synonym: alimentary diabetes, digestive glycosuria.
(05 Mar 2000)
alloxan diabetes Experimental diabetes mellitus produced in animals by the administration of alloxan, which damages the insulin-producing islet cells of the pancreas.
(05 Mar 2000)
brittle diabetes <endocrinology> A term used when the blood glucose (sugar) level often swings quickly from high to low and from low to high and is somewhat unstable.
(13 Nov 1997)
bronzed diabetes A genetic disease in which the body takes in too much iron from food, this causes excess iron to be deposited in the liver and heart and other organs, eventually leading to organ failure and death.
This illness is called bronze diabetes because the kidneys often fail, leading to symptoms similar to those found with diabetes mellitus, and because the deposition of iron into the skin makes the person look like he or she has an all-over tan.
It used to be believed that this disease was rare and mainly affected people of Caucasian descent, butin recent years scientists have realised it is more common and affects a wide range of ethnic groups. Some believe that this genetic defect actually helps people (especially women) survive in areas where malnutrition is widespread and iron is scarce in food.
Regular venesection may help people suffering from this disease.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obesity
    ºñ¸¸;ºñ´ë
  • diabetes
    ´ç´¢º´
  • diabetes insipidus
    (º´¸®)¿äºØÁõ
  • diabetes mellitus
    (º´¸®)Áø¼º ´ç´¢º´
  • maturityonset diabetes
    Áß;³ë³â¼º ´ç´¢º´
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á